Insiders Neurocrine Biosciences, Inc.

Equities

NBIX

US64125C1099

Delayed Nasdaq Other stock markets 01:26:23 11/05/2024 am IST			5-day change	1st Jan Change
136.7 ^USD	-2.11%		-2.96%	+3.64%

08/05	Neurocrine Biosciences, Inc. Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults	CI
07/05	Neurocrine Biosciences to Present Phase 3 Baseline Characteristics Data from the CAHtalyst? Program of Crinecerfont in CAH, and Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH Studies at ECE 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Neurocrine Biosciences Insider Sold Shares Worth $5,576,710, According to a Recent SEC Filing	16/03	MT
Neurocrine Biosciences Insider Sold Shares Worth $420,419, According to a Recent SEC Filing	16/03	MT
Neurocrine Biosciences Insider Sold Shares Worth $922,632, According to a Recent SEC Filing	01/03	MT
Neurocrine Biosciences Insider Sold Shares Worth $1,085,388, According to a Recent SEC Filing	01/03	MT
Neurocrine Biosciences Insider Sold Shares Worth $1,987,047, According to a Recent SEC Filing	23/02	MT
Neurocrine Biosciences Insider Sold Shares Worth $376,700, According to a Recent SEC Filing	16/02	MT
Neurocrine Biosciences Insider Sold Shares Worth $313,530, According to a Recent SEC Filing	09/02	MT
Neurocrine Biosciences Insider Sold Shares Worth $290,968, According to a Recent SEC Filing	09/02	MT
Neurocrine Biosciences Insider Sold Shares Worth $359,041, According to a Recent SEC Filing	09/02	MT
Neurocrine Biosciences Insider Sold Shares Worth $737,271, According to a Recent SEC Filing	09/02	MT
Neurocrine Biosciences Insider Sold Shares Worth $270,284, According to a Recent SEC Filing	09/02	MT
Neurocrine Biosciences Insider Sold Shares Worth $352,612, According to a Recent SEC Filing	09/02	MT
Neurocrine Biosciences Insider Sold Shares Worth $1,398,553, According to a Recent SEC Filing	25/01	MT
Neurocrine Biosciences Insider Sold Shares Worth $22,328,417, According to a Recent SEC Filing	11/01	MT
Neurocrine Biosciences Insider Sold Shares Worth $1,451,927, According to a Recent SEC Filing	05/01	MT
Neurocrine Biosciences Insider Sold Shares Worth $9,860,194, According to a Recent SEC Filing	05/01	MT
Neurocrine Biosciences Insider Sold Shares Worth $1,300,443, According to a Recent SEC Filing	28/12	MT
Neurocrine Biosciences Insider Sold Shares Worth $3,087,808, According to a Recent SEC Filing	28/12	MT
Neurocrine Biosciences Insider Sold Shares Worth $1,267,448, According to a Recent SEC Filing	28/12	MT
Neurocrine Biosciences Insider Sold Shares Worth $1,675,240, According to a Recent SEC Filing	15/12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Neurocrine Biosciences, Inc.

Equities

NBIX

US64125C1099

Insiders

Filters